To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open453
High458.95
Low430.45
Prev. Close442.05
Avg. Traded Price440.45
Volume50,965

MARKET DEPTH

info2
Total bid4.00
Total ask0.00
OrdersQtyBid
14442.05
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

430.4512 hours ago
458.9516 hours ago
arrow

LOWER/UPPER CIRCUITS

430.45
475.75
arrow
Venus Remedies Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 9.1%, in the last year to ₹668.84 Cr. Its sector's average revenue growth for the last fiscal year was 10.53%.
noteAnnual Net Profit,rose 59.05% in the last year to ₹45.31 Cr. Its sector's average net profit growth for the last fiscal year was 36.7%.
notePrice to Earning Ratio,is 11.28, lower than its sector PE ratio of 41.72.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 58.09%
Net profit growth 5Y CAGR : %
Venus Remedies Limited is a research and innovation-driven Indian pharmaceutical company with a global footprint in many nations. The company has several manufacturing facilities, hundreds of market authorisations, many global patents and product basket. Its GLP-accredited Venus Medicine Research Centre (VMRC) is committed to offering the world novel breakthroughs catering to the critical care and super specialty segments. Its manufacturing facilities deliver world-class products accepted by regulators in advanced and developing pharmaceutical markets.
personal

Grow your wealth with more research recommendations

+91